[1]
Sleire, L.; Førde, H.E.; Netland, I.A.; Leiss, L.; Skeie, B.S.; Enger, P.∅. Drug repurposing in cancer; Pharma. Res, 2017, pp. 74-91.
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[2]
Khachigian, L.M. Repurposing drugs for skin cancer. Curr. Med. Chem., 2020, 27(42), 7214-7221.
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[3]
Torralba, M.; Farra, R.; Maddaloni, M.; Grassi, M.; Dapas, B.; Grassi, G. Drugs repurposing in high-grade serous ovarian cancer. Curr. Med. Chem., 2020, 27(42), 7222-7233.
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[4]
Fernandes, S.; Cassani, M.; Pagliari, S.; Filipensky, P.; Cavalieri, F.; Forte, G. Tumor in 3D: in vitro complex cellular models to improve nanodrugs cancer therapy. Curr. Med. Chem., 2020, 27(42), 7234-7255.
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
Current Medicinal Chemistry
Title:Drug Repurposing in Human Cancers
Volume: 27 Issue: 42
Author(s): Gabriele Grassi and Mario Grassi
Affiliation:
Export Options
About this article
Cite this article as:
Grassi Gabriele and Grassi Mario , Drug Repurposing in Human Cancers, Current Medicinal Chemistry 2020; 27 (42) . https://dx.doi.org/10.2174/092986732742201105104417
DOI https://dx.doi.org/10.2174/092986732742201105104417 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
12
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design High-component Reactions (HCRs): An Overview of MCRs Containing Seven or More Components as Versatile Tools in Organic Synthesis
Current Organic Synthesis Perspective on Nanoparticle Technology for Biomedical Use
Current Pharmaceutical Design Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression
Recent Patents on DNA & Gene Sequences Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics
Current Medicinal Chemistry Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy
Current Drug Metabolism Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling
Anti-Cancer Agents in Medicinal Chemistry Estrogens and Progression of Diabetic Kidney Damage
Current Diabetes Reviews Exploring Single Nucleotide Polymorphisms in ITGAV for Gastric, Pancreatic and Liver Malignancies: An Approach Towards the Discovery of Biomarker
Combinatorial Chemistry & High Throughput Screening Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases
Current Pharmacogenomics and Personalized Medicine Cancer-Type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives
Current Drug Metabolism Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer's Disease and Other Tauopathies
Current Drug Delivery Current Issues in the Utility of Blood Oxygen Level Dependent MRI for the Assessment of Modulations in Tumor Oxygenation
Current Medical Imaging Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
Current Drug Safety Proteomic Technologies and their Application for Ensuring Meat Quality, Safety and Authenticity
Current Proteomics Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect
Current Pharmaceutical Biotechnology Structure-Activity Relationship of Supramolecular Compounds in Drug Delivery
Mini-Reviews in Organic Chemistry